Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Development and validation of a food frequency questionnaire in a randomized trial of eye diseases
1999
Group, A.R.Eye Diseas
Discontinuation of ant cytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
1999
Whitcup, S.M., Fortin, E., Lindblad, A.S., Griffiths, P., Metcalf, J.A., Robinson, M.R., Manischewitz, J., Baird, B., Perry, C., Kidd, I.M., Vrabec, T., Davey, R.T., Falloon, J., Walker, R.E., Kovacs, J.A., Lane, H.C., Nussenblatt, R.B., Smith, J., Masur, H., Polis, M.A.
Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine
02/2000
Belshe, R.B., Gruber, W., Mendelman, P.M., Cho, I., Reisinger, K., Block, S., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D.I., Hayden, F.G., Zangwill, K., Yan, L., Wolff, M.C.
Evaluation of pre- and post-transplant DST/CsA in non-HLA identical living donor kidney transplant recipients
1999
Alexander, J., Light, J., Donaldson, L., Delmonico, F., Diethelm, A., Wilkinson, A., Thistlethwaite, J., Hunsicker, L., Matas, J., Reinsmoen, N., Rose, S.
Graft loss due to recurrence eliminates the graft survival advantage of living donor (LD) over Cadaveric (CD) renal transplants (Tx) in children with focal segmental glomerulosclerosis (FSGS): A report of the North American Pediatric Transplant Cooperati
1999
Baum, M.A., Stablein, D., Panzarino, V.M., Tejani, A., Harmon, W.
Should living-related renal transplant be performed for primary oxalosis?
2000
Tejani, A., Sullivan, E.K.